Birdwatch Note
2022-09-02 13:05:20 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
This tweet is incorrect. Ivermectin has been addressed on this page since it was first created in June 2021, as seen by the Internet Archive: https://web.archive.org/web/20210612061731/https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ The content about Ivermectin specifically can be viewed over time here: https://web.archive.org/web/20210301000000*/https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ivermectin/ The NIH has not changed its position.
Written by C84C94ABA27F04C1E8A94894C1CC87F6
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1565086552580956160
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1565687317456719872
- noteId - 1565687317456719872
- participantId - C84C94ABA27F04C1E8A94894C1CC87F6
- noteAuthorParticipantId -
- createdAtMillis - 1662123920204
- tweetId - 1565086552580956160
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable - BELIEVABLE_BY_FEW
- harmful - CONSIDERABLE_HARM
- validationDifficulty - EASY
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- This tweet is incorrect. Ivermectin has been addressed on this page since it was first created in June 2021, as seen by the Internet Archive: https://web.archive.org/web/20210612061731/https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ The content about Ivermectin specifically can be viewed over time here: https://web.archive.org/web/20210301000000*/https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ivermectin/ The NIH has not changed its position.
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2022-09-02 13:05:20 UTC (1662123920204) |
2022-09-02 23:03:17 UTC (1662159797115) |
CURRENTLY_RATED_HELPFUL | 2022-09-02 23:03:17 UTC (1662159797115) |
CURRENTLY_RATED_HELPFUL | 2022-09-02 23:03:17 UTC (1662159797115) |
CURRENTLY_RATED_HELPFUL | C84C94ABA27F04C1E8A94894C1CC87F6 |
| 2022-09-02 13:05:20 UTC (1662123920204) |
2022-09-02 23:03:17 UTC (1662159797115) |
CURRENTLY_RATED_HELPFUL | 2022-09-02 23:03:17 UTC (1662159797115) |
CURRENTLY_RATED_HELPFUL | 2022-09-02 23:03:17 UTC (1662159797115) |
CURRENTLY_RATED_HELPFUL | B7B73541F2424A390C0FDE0AC71FAAE547409BADBB49F935B736ABB068A08BD1 |
Note Ratings
| rated at | rated by | |
| 2022-09-06 09:32:18 -0500 | 00419D894C8ED5B82DC275D82336289EDBC5D09327F8952EDCA5842D2C07571F | Rating Details |
| 2022-09-09 13:51:18 -0500 | 0A8CE079652FABEE1E70C7CA5A76941E | Rating Details |
| 2022-09-09 11:42:52 -0500 | 0B683F53A71314B5B037053E967D8B7476EE62CEC7C245474E462A3294BE2995 | Rating Details |
| 2022-09-02 19:19:19 -0500 | 0C91900F7892D8DA899BB85193A8758A | Rating Details |
| 2022-09-02 11:51:24 -0500 | 10577C7A53E96EBDCC738006BA2745C47E5C1033B65650C044881BBECCF0F738 | Rating Details |
| 2022-09-03 11:19:11 -0500 | 114EBF4541A873C438A90173BEF49CC0 | Rating Details |
| 2022-09-05 06:49:03 -0500 | 152C664EC474246EB3D5BD53CBEFF1A9 | Rating Details |
| 2022-09-04 14:43:49 -0500 | 16C91E54A7232BDE0FF774872C56D797 | Rating Details |
| 2022-09-06 16:20:03 -0500 | 1E369486E7334354C993FD46239ED17A | Rating Details |
| 2022-09-03 08:11:50 -0500 | 1FD3531B25C50D7EF4D39841AB0D6B45 | Rating Details |
| 2022-09-05 10:39:16 -0500 | 227B72516F48209D4CD398BD566B39A53B64980200BCA4A4C749072F49AA8384 | Rating Details |
| 2022-09-02 08:25:54 -0500 | 24F50C727DFEC6559A845D56A74EC0D2 | Rating Details |
| 2022-09-06 15:51:39 -0500 | 29C258431C6C5755D048EBDED185C07F | Rating Details |
| 2022-09-03 08:11:50 -0500 | 39B227503DDBD00A7B2EC9D5346524051246968122B30EF0B46ABB7E54777B00 | Rating Details |
| 2022-09-03 10:39:19 -0500 | 3A0197C659EC4376B42DB468BAC93BF228451114B2B72A8EFE0685B1B7C76A3F | Rating Details |
| 2022-09-02 16:48:22 -0500 | 47AD3BD4ED0E64C9EA74DB3A322FA6AA5E5F8D84E57A6E405CC624F53C571EC8 | Rating Details |
| 2022-09-04 06:57:32 -0500 | 491F86E495D57AD373CE546FA4D9E4C79AB3B56F4BD9907D2CD96BB4578540B1 | Rating Details |
| 2022-09-02 17:59:16 -0500 | 51CF24E741A18508E181F80408E6E7E109FDDE98B31A9F11F05480731FF485A6 | Rating Details |
| 2022-09-02 17:40:26 -0500 | 58DF54439BB87FA9A8B079053E570A66 | Rating Details |
| 2022-09-02 17:59:16 -0500 | 5AD0B5581E4AC4683F4A8D75DEB62680 | Rating Details |
| 2022-09-02 08:07:00 -0500 | 5D0176DDAA81304936444BDF6AE28F7CAD211A2A39059662E297C918C3FE83FB | Rating Details |
| 2022-09-23 09:59:16 -0500 | 6093F87E1E5100494809663D46D210B648FA95FB972E0C16A4A45EA7A321BC9E | Rating Details |
| 2022-09-07 16:25:32 -0500 | 61DA240E361A19DBE358CCC01F4C87F41DE56B275C3A3F10D576C8BD04E0D64A | Rating Details |
| 2022-09-27 21:23:12 -0500 | 6B47CDCB4F4AAA06F80C0DFBD31E36E151B87E5F9D7E86D1C0F7DF1CD9C6DDF7 | Rating Details |
| 2022-09-04 11:59:22 -0500 | 6C4D39819380C974F26A34B6C85405BD | Rating Details |
| 2022-09-03 08:18:39 -0500 | 6FE967971F633416C6B991BB9680FB03 | Rating Details |
| 2022-09-02 16:51:16 -0500 | 793F32EC570AE7797B0DB2F804C4EDC0595B0BAC059AE27CEA6D7E7D2DE97FC1 | Rating Details |
| 2022-09-03 08:58:40 -0500 | 872096B1787AC0AD02CD55CF07B21EFA966FF41F61D366C6479B792AF5D855FA | Rating Details |
| 2022-09-23 09:59:16 -0500 | 8C9F1DBF40E1A4EDB6DBDE1BFC6E7861 | Rating Details |
| 2022-09-06 16:00:45 -0500 | 8E9096B7E6E4E974B420CCA85B6428EF38EB42D93D17DAE48B11C7E1BB1D457F | Rating Details |
| 2022-09-02 16:48:22 -0500 | 9795BF8962792425EFA8D2F4F92685B4 | Rating Details |
| 2022-09-02 11:51:24 -0500 | 9B9A5FC5EF7605A76107298D4A5785A1 | Rating Details |
| 2022-09-02 17:40:26 -0500 | 9D63BA103D90D8A76C6AE87E7D28DC98DD609186A0BDB59AB7FE8975ADA24401 | Rating Details |
| 2022-09-02 12:18:23 -0500 | 9E106D628FFB84FBF4BEF250CE7933527334F470AA57B82B2630C725FBF55706 | Rating Details |
| 2022-09-04 11:59:22 -0500 | 9FDF9893DFAB4D45202E6558FAE3342DA24DFA5D58A9F7C14A2CF2DD79A3E176 | Rating Details |
| 2022-09-05 06:49:03 -0500 | A227869B752DF62F7538C29F2D2D225BAE499F3095FF33A985D81DD1C622A0E8 | Rating Details |
| 2022-09-02 19:19:19 -0500 | A30E23B01F927C4387616E33DE422C96B4F9A9B45B8ACA619267391F3D77B5A8 | Rating Details |
| 2022-09-05 09:29:30 -0500 | A5C3AC0D8A4ADC7FDE7D32CFDA99A5A564C5B9DDFEFA352441651A6476FEDD7B | Rating Details |
| 2022-09-03 00:53:55 -0500 | AE8070921516817FCDAE1CE1EDF7A67A034246D2643057829AA73C88E3C85B53 | Rating Details |
| 2022-09-24 12:26:48 -0500 | AF3F4928D4AB96D026E045A1DF8B6E68726139214D2FEDD61FD0CFAD14B180D7 | Rating Details |
| 2022-09-03 08:58:40 -0500 | B26D177FD7C31B8C43E1AC2834E2FF23 | Rating Details |
| 2022-09-02 08:25:54 -0500 | B2C506045451222FC7E5C5EE7FE7F2AD00C2FEF765E2C0F4E6FACB90D2429539 | Rating Details |
| 2022-09-05 10:39:16 -0500 | B47391ADD314142E98ADB1447C70FB98 | Rating Details |
| 2022-09-06 15:51:39 -0500 | C9F3CEF002A205EA79127A7ABAFE63997557EE4A5D3883C33029BDD1D9AF6B4B | Rating Details |
| 2022-09-06 09:32:18 -0500 | CA61954CDF1F587A2B94DD21DD4969E6 | Rating Details |
| 2022-09-04 06:57:32 -0500 | CD9D49DCCCDDE369B34482B66E49E224 | Rating Details |
| 2022-09-06 16:20:03 -0500 | D1A4BA179F884EF4A94651A83807B6C2F9DE401B8B8A42F898C00F16CF50FE0E | Rating Details |
| 2022-09-02 12:18:23 -0500 | D54F795CF0826F8850129E332F4C529A | Rating Details |
| 2022-09-06 16:00:45 -0500 | D6C9F18D84F1AFF2F03E1D1EF037B6A2 | Rating Details |
| 2022-09-09 11:42:52 -0500 | DA4507E4409ABAABB16D1F142ADEA36B | Rating Details |
| 2022-09-05 09:29:30 -0500 | E18615A2184F0EB382A06E907D3EA380 | Rating Details |
| 2022-09-02 08:11:16 -0500 | E56CE5AC74E4149EADF7874694F17DBAF195BE6E6C11E26876B22BAC2DAB0035 | Rating Details |
| 2022-09-09 13:51:18 -0500 | E7C7934755CA3B53B9708C5E1E440AA9EBDC92893472617EF7D174F1A693D69E | Rating Details |
| 2022-09-02 08:07:00 -0500 | E991CD0237C2AD90C8F5E00C61B6E1CC | Rating Details |
| 2022-09-03 11:19:11 -0500 | EB438CF6B4E1C661BB9543EF156E26CB7A8DE887BC6588C08468D52D8D61F352 | Rating Details |
| 2022-09-02 08:11:16 -0500 | EC479171541C61613ABD776DEC11A1C5 | Rating Details |
| 2022-09-03 10:39:19 -0500 | F2C1B194EB06BA309FFF88281581CC09 | Rating Details |
| 2022-09-07 16:25:32 -0500 | F7AD37CF0ED4DE532842DE6B09320D6D | Rating Details |
| 2022-09-04 14:43:49 -0500 | FECF4569ACEDBFCE4E418E90B2504B21DD4E553E81C8982DE5364A8024E84C2B | Rating Details |
| 2022-09-03 08:18:39 -0500 | FED73511F2BDB5E86905A1B066D6FDFAE369016A825E47935EF7CC1AE1CE000F | Rating Details |
| 2022-09-02 16:51:16 -0500 | FF928498F12DA3C93C7941B1FEA1199B | Rating Details |
| 2022-09-07 08:14:07 -0500 | Rating Details | |
| 2022-09-03 22:28:43 -0500 | Rating Details | |
| 2023-01-06 19:28:03 -0600 | Rating Details | |
| 2022-09-21 21:26:33 -0500 | Rating Details | |
| 2022-09-06 16:58:16 -0500 | Rating Details | |
| 2022-09-04 13:00:46 -0500 | Rating Details | |
| 2022-10-28 08:35:43 -0500 | Rating Details | |
| 2022-09-03 10:39:19 -0500 | Rating Details | |
| 2022-09-09 11:42:52 -0500 | Rating Details | |
| 2022-09-07 16:25:32 -0500 | Rating Details | |
| 2022-09-02 17:40:26 -0500 | Rating Details | |
| 2022-09-07 08:14:07 -0500 | Rating Details | |
| 2022-09-03 22:28:43 -0500 | Rating Details | |
| 2022-09-02 08:07:00 -0500 | Rating Details | |
| 2023-01-06 19:28:03 -0600 | Rating Details | |
| 2022-09-06 15:51:39 -0500 | Rating Details | |
| 2022-09-03 08:11:50 -0500 | Rating Details | |
| 2022-09-05 09:29:30 -0500 | Rating Details | |
| 2022-09-05 06:49:03 -0500 | Rating Details | |
| 2022-09-02 08:11:16 -0500 | Rating Details | |
| 2022-09-03 11:19:11 -0500 | Rating Details | |
| 2022-09-04 06:57:32 -0500 | Rating Details | |
| 2022-09-04 14:43:49 -0500 | Rating Details | |
| 2022-09-21 21:26:33 -0500 | Rating Details | |
| 2022-09-06 09:32:18 -0500 | Rating Details | |
| 2022-09-09 13:51:18 -0500 | Rating Details | |
| 2022-09-02 11:51:24 -0500 | Rating Details | |
| 2022-09-04 11:59:22 -0500 | Rating Details | |
| 2022-09-03 08:18:39 -0500 | Rating Details | |
| 2022-09-06 16:00:45 -0500 | Rating Details | |
| 2022-09-06 16:58:16 -0500 | Rating Details | |
| 2022-09-02 08:25:54 -0500 | Rating Details | |
| 2022-09-04 13:00:46 -0500 | Rating Details | |
| 2022-09-03 08:58:40 -0500 | Rating Details | |
| 2022-09-02 12:18:23 -0500 | Rating Details | |
| 2022-09-02 19:19:19 -0500 | Rating Details | |
| 2022-09-02 17:59:16 -0500 | Rating Details | |
| 2022-09-02 16:51:16 -0500 | Rating Details | |
| 2022-09-05 10:39:16 -0500 | Rating Details | |
| 2022-09-03 00:53:55 -0500 | Rating Details | |
| 2022-09-06 16:20:03 -0500 | Rating Details | |
| 2022-10-28 08:35:43 -0500 | Rating Details | |
| 2022-09-23 09:59:16 -0500 | Rating Details | |
| 2022-09-02 16:48:22 -0500 | Rating Details | |
| 2022-09-24 12:26:48 -0500 | Rating Details | |
| 2024-07-01 08:01:40 -0500 | Rating Details |